These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7408396

  • 1. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors.
    Pazmiño PA, Sladek SL, Weinshilboum RM.
    Clin Pharmacol Ther; 1980 Sep; 28(3):356-67. PubMed ID: 7408396
    [Abstract] [Full Text] [Related]

  • 2. Methyl conjugation in uraemia: catechol-O-methyltransferase.
    Pazmiño PA, Weinshilboum RM.
    Br J Clin Pharmacol; 1980 Nov; 10(5):509-18. PubMed ID: 7437264
    [Abstract] [Full Text] [Related]

  • 3. Human pharmacogenetics of methyl conjugation.
    Weinshilboum RM.
    Fed Proc; 1984 May 15; 43(8):2303-7. PubMed ID: 6714437
    [Abstract] [Full Text] [Related]

  • 4. Human thiopurine S-methyltransferase activity in uremia and after renal transplantation.
    Weyer N, Kröplin T, Fricke L, Iven H.
    Eur J Clin Pharmacol; 2001 May 15; 57(2):129-36. PubMed ID: 11417444
    [Abstract] [Full Text] [Related]

  • 5. Methylation pharmacogenetics: thiopurine methyltransferase as a model system.
    Weinshilboum RM.
    Xenobiotica; 1992 May 15; 22(9-10):1055-71. PubMed ID: 1441597
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.
    Weinshilboum RM, Sladek SL.
    Am J Hum Genet; 1980 Sep 15; 32(5):651-62. PubMed ID: 7191632
    [Abstract] [Full Text] [Related]

  • 8. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
    Lennard L, Van Loon JA, Lilleyman JS, Weinshilboum RM.
    Clin Pharmacol Ther; 1987 Jan 15; 41(1):18-25. PubMed ID: 3467886
    [Abstract] [Full Text] [Related]

  • 9. Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.
    Glauser TA, Nelson AN, Zembower DE, Lipsky JJ, Weinshilboum RM.
    J Pharmacol Exp Ther; 1993 Jul 15; 266(1):23-32. PubMed ID: 8392551
    [Abstract] [Full Text] [Related]

  • 10. Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties.
    Weinshilboum RM, Raymond FA, Pazmiño PA.
    Clin Chim Acta; 1978 May 02; 85(3):323-33. PubMed ID: 657528
    [Abstract] [Full Text] [Related]

  • 11. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.
    Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM.
    Pharmacogenetics; 1992 Aug 02; 2(4):148-59. PubMed ID: 1306116
    [Abstract] [Full Text] [Related]

  • 12. Thiol methylation pharmacogenetics: heritability of human erythrocyte thiol methyltransferase activity.
    Keith RA, Van Loon J, Wussow LF, Weinshilboum RM.
    Clin Pharmacol Ther; 1983 Oct 02; 34(4):521-8. PubMed ID: 6617076
    [Abstract] [Full Text] [Related]

  • 13. Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives.
    Woodson LC, Ames MM, Selassie CD, Hansch C, Weinshilboum RM.
    Mol Pharmacol; 1983 Nov 02; 24(3):471-8. PubMed ID: 6633508
    [Abstract] [Full Text] [Related]

  • 14. Variability in the rate of 6-mercaptopurine methylation in the erythrocytes, liver and kidney in an Italian population.
    Ferroni MA, Marchi G, Sansone E, Romeo P, Giulianotti PC, Pietrabissa A, Mosca F, Pacifici GM.
    Eur J Clin Pharmacol; 1996 Nov 02; 51(1):23-9. PubMed ID: 8880047
    [Abstract] [Full Text] [Related]

  • 15. Erythrocyte fraction affects red blood cell thiopurine methyltransferase activity.
    Klemetsdal B, Straume B, Lysaa R, Giverhaug T, Aarbakke J.
    Eur J Clin Pharmacol; 1995 Nov 02; 48(6):495-9. PubMed ID: 8582469
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human erythrocyte phenol-O-methyltransferase in uremia.
    Pazminño P, Rogoff F, Weinshilboum R.
    Clin Pharmacol Ther; 1979 Oct 02; 26(4):464-72. PubMed ID: 487694
    [No Abstract] [Full Text] [Related]

  • 17. Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population.
    Klemetsdal B, Straume B, Wist E, Aarbakke J.
    Eur J Clin Pharmacol; 1993 Oct 02; 44(2):147-52. PubMed ID: 8453958
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements.
    Kröplin T, Fischer C, Iven H.
    Eur J Clin Pharmacol; 1999 Jun 02; 55(4):285-91. PubMed ID: 10424321
    [Abstract] [Full Text] [Related]

  • 19. Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia.
    Chrzanowska M, Kuehn M, Januszkiewicz-Lewandowska D, Kurzawski M, Droździk M.
    Acta Pol Pharm; 2012 Jun 02; 69(3):405-10. PubMed ID: 22594254
    [Abstract] [Full Text] [Related]

  • 20. Thiopurine methyltransferase activity in a Korean population sample of children.
    Park-Hah JO, Klemetsdal B, Lysaa R, Choi KH, Aarbakke J.
    Clin Pharmacol Ther; 1996 Jul 02; 60(1):68-74. PubMed ID: 8689814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.